Fig. 1From: Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challengesOverview of the relevant requirements for institution of stem cell-derived therapy clinically, including β-like cells. cGMP: Current good manufacturing practice. iPSC: Induced pluripotent stem cell; ESC: embryonic stem cellBack to article page